Global Biopharmaceutical CDMO Service Market Growth (Status and Outlook) 2026-2032
The global Biopharmaceutical CDMO Service market size is predicted to grow from US$ 30800 million in 2025 to US$ 74150 million in 2032; it is expected to grow at a CAGR of 13.6% from 2026 to 2032.
Biopharmaceutical Contract Development and Manufacturing Organizations (CDMOs) are companies that provide comprehensive services for the development and manufacturing of biopharmaceutical products. These organizations play a crucial role in the biopharmaceutical industry by offering a range of services to biotech and pharmaceutical companies, allowing them to outsource various stages of the drug development and manufacturing process.
Increasing Demand for Biologics: The rising demand for biopharmaceuticals, including monoclonal antibodies, recombinant proteins, and gene therapies, is a significant driver. Biologics are increasingly becoming a focus for drug development due to their effectiveness in treating various diseases.
Cost-Effective Outsourcing: Outsourcing to CDMOs allows pharmaceutical and biotech companies to reduce capital expenditures, mitigate risks, and achieve cost savings. CDMOs offer specialized facilities and expertise, allowing clients to avoid the need for extensive in-house infrastructure.
Strategic Partnerships and Collaborations: Pharmaceutical and biotech companies increasingly engage in strategic partnerships with CDMOs to access specialized capabilities, share development risks, and benefit from the CDMO's expertise in specific technologies or therapeutic areas.
To meet the growing demand for biopharmaceuticals, CDMOs are investing in expanding their biomanufacturing capacities. This includes the construction of new facilities and the acquisition of advanced technologies to increase production capabilities.
The increasing interest and investment in cell and gene therapies have led to a rise in demand for CDMOs offering services in this area. Companies are seeking expertise in cell line development, viral vector production, and other specialized services related to advanced therapies.
Biopharmaceutical CDMOs are expanding their global presence to cater to the needs of a geographically diverse client base. This includes establishing facilities in key regions and forming strategic partnerships to enhance their global reach.
CDMOs are expanding their service offerings to provide integrated solutions covering the entire biopharmaceutical development and manufacturing lifecycle. This integrated approach aims to streamline processes and accelerate time to market for clients.
LPI (LP Information)' newest research report, the “Biopharmaceutical CDMO Service Industry Forecast” looks at past sales and reviews total world Biopharmaceutical CDMO Service sales in 2025, providing a comprehensive analysis by region and market sector of projected Biopharmaceutical CDMO Service sales for 2026 through 2032. With Biopharmaceutical CDMO Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biopharmaceutical CDMO Service industry.
This Insight Report provides a comprehensive analysis of the global Biopharmaceutical CDMO Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Biopharmaceutical CDMO Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biopharmaceutical CDMO Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biopharmaceutical CDMO Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biopharmaceutical CDMO Service.
This report presents a comprehensive overview, market shares, and growth opportunities of Biopharmaceutical CDMO Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
Biopharmaceutical Contract Development and Manufacturing Organizations (CDMOs) are companies that provide comprehensive services for the development and manufacturing of biopharmaceutical products. These organizations play a crucial role in the biopharmaceutical industry by offering a range of services to biotech and pharmaceutical companies, allowing them to outsource various stages of the drug development and manufacturing process.
Increasing Demand for Biologics: The rising demand for biopharmaceuticals, including monoclonal antibodies, recombinant proteins, and gene therapies, is a significant driver. Biologics are increasingly becoming a focus for drug development due to their effectiveness in treating various diseases.
Cost-Effective Outsourcing: Outsourcing to CDMOs allows pharmaceutical and biotech companies to reduce capital expenditures, mitigate risks, and achieve cost savings. CDMOs offer specialized facilities and expertise, allowing clients to avoid the need for extensive in-house infrastructure.
Strategic Partnerships and Collaborations: Pharmaceutical and biotech companies increasingly engage in strategic partnerships with CDMOs to access specialized capabilities, share development risks, and benefit from the CDMO's expertise in specific technologies or therapeutic areas.
To meet the growing demand for biopharmaceuticals, CDMOs are investing in expanding their biomanufacturing capacities. This includes the construction of new facilities and the acquisition of advanced technologies to increase production capabilities.
The increasing interest and investment in cell and gene therapies have led to a rise in demand for CDMOs offering services in this area. Companies are seeking expertise in cell line development, viral vector production, and other specialized services related to advanced therapies.
Biopharmaceutical CDMOs are expanding their global presence to cater to the needs of a geographically diverse client base. This includes establishing facilities in key regions and forming strategic partnerships to enhance their global reach.
CDMOs are expanding their service offerings to provide integrated solutions covering the entire biopharmaceutical development and manufacturing lifecycle. This integrated approach aims to streamline processes and accelerate time to market for clients.
LPI (LP Information)' newest research report, the “Biopharmaceutical CDMO Service Industry Forecast” looks at past sales and reviews total world Biopharmaceutical CDMO Service sales in 2025, providing a comprehensive analysis by region and market sector of projected Biopharmaceutical CDMO Service sales for 2026 through 2032. With Biopharmaceutical CDMO Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biopharmaceutical CDMO Service industry.
This Insight Report provides a comprehensive analysis of the global Biopharmaceutical CDMO Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Biopharmaceutical CDMO Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biopharmaceutical CDMO Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biopharmaceutical CDMO Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biopharmaceutical CDMO Service.
This report presents a comprehensive overview, market shares, and growth opportunities of Biopharmaceutical CDMO Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Cell and Gene Therapies
- Antibodies
- Vaccines
- Other
- SMBs
- Large Companies
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Lonza
- Catalent
- Samsung Biologics
- FUJIFILM Diosynth Biotechnologies
- Boehringer Ingelheim
- WuXi Biologics
- Recipharm
- Thermo Fisher Scientific
- AGC Biologics
- Rentschler Biopharma
- KBI Biopharma
- Siegfried
- Aenova Group
- GenScript
- ProBioGen
- Northway Biotech
- 3P Biopharmaceuticals
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biopharmaceutical CDMO Service Market Size (2021-2032)
2.1.2 Biopharmaceutical CDMO Service Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Biopharmaceutical CDMO Service by Country/Region (2021, 2025 & 2032)
2.2 Biopharmaceutical CDMO Service Segment by Type
2.2.1 Cell and Gene Therapies
2.2.2 Antibodies
2.2.3 Vaccines
2.2.4 Other
2.2.5 Biopharmaceutical CDMO Service Market Size by Type
2.2.5.1 Biopharmaceutical CDMO Service Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Biopharmaceutical CDMO Service Market Size Market Share by Type (2021-2026)
2.3 Biopharmaceutical CDMO Service Segment by Application
2.3.1 SMBs
2.3.2 Large Companies
2.3.3 Biopharmaceutical CDMO Service Market Size by Application
2.3.3.1 Biopharmaceutical CDMO Service Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.3.2 Global Biopharmaceutical CDMO Service Market Size Market Share by Application (2021-2026)
3 BIOPHARMACEUTICAL CDMO SERVICE MARKET SIZE BY PLAYER
3.1 Biopharmaceutical CDMO Service Market Size Market Share by Player
3.1.1 Global Biopharmaceutical CDMO Service Revenue by Player (2021-2026)
3.1.2 Global Biopharmaceutical CDMO Service Revenue Market Share by Player (2021-2026)
3.2 Global Biopharmaceutical CDMO Service Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 BIOPHARMACEUTICAL CDMO SERVICE BY REGION
4.1 Biopharmaceutical CDMO Service Market Size by Region (2021-2026)
4.2 Global Biopharmaceutical CDMO Service Annual Revenue by Country/Region (2021-2026)
4.3 Americas Biopharmaceutical CDMO Service Market Size Growth (2021-2026)
4.4 APAC Biopharmaceutical CDMO Service Market Size Growth (2021-2026)
4.5 Europe Biopharmaceutical CDMO Service Market Size Growth (2021-2026)
4.6 Middle East & Africa Biopharmaceutical CDMO Service Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Biopharmaceutical CDMO Service Market Size by Country (2021-2026)
5.2 Americas Biopharmaceutical CDMO Service Market Size by Type (2021-2026)
5.3 Americas Biopharmaceutical CDMO Service Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biopharmaceutical CDMO Service Market Size by Region (2021-2026)
6.2 APAC Biopharmaceutical CDMO Service Market Size by Type (2021-2026)
6.3 APAC Biopharmaceutical CDMO Service Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Biopharmaceutical CDMO Service Market Size by Country (2021-2026)
7.2 Europe Biopharmaceutical CDMO Service Market Size by Type (2021-2026)
7.3 Europe Biopharmaceutical CDMO Service Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biopharmaceutical CDMO Service by Region (2021-2026)
8.2 Middle East & Africa Biopharmaceutical CDMO Service Market Size by Type (2021-2026)
8.3 Middle East & Africa Biopharmaceutical CDMO Service Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL BIOPHARMACEUTICAL CDMO SERVICE MARKET FORECAST
10.1 Global Biopharmaceutical CDMO Service Forecast by Region (2027-2032)
10.1.1 Global Biopharmaceutical CDMO Service Forecast by Region (2027-2032)
10.1.2 Americas Biopharmaceutical CDMO Service Forecast
10.1.3 APAC Biopharmaceutical CDMO Service Forecast
10.1.4 Europe Biopharmaceutical CDMO Service Forecast
10.1.5 Middle East & Africa Biopharmaceutical CDMO Service Forecast
10.2 Americas Biopharmaceutical CDMO Service Forecast by Country (2027-2032)
10.2.1 United States Market Biopharmaceutical CDMO Service Forecast
10.2.2 Canada Market Biopharmaceutical CDMO Service Forecast
10.2.3 Mexico Market Biopharmaceutical CDMO Service Forecast
10.2.4 Brazil Market Biopharmaceutical CDMO Service Forecast
10.3 APAC Biopharmaceutical CDMO Service Forecast by Region (2027-2032)
10.3.1 China Biopharmaceutical CDMO Service Market Forecast
10.3.2 Japan Market Biopharmaceutical CDMO Service Forecast
10.3.3 Korea Market Biopharmaceutical CDMO Service Forecast
10.3.4 Southeast Asia Market Biopharmaceutical CDMO Service Forecast
10.3.5 India Market Biopharmaceutical CDMO Service Forecast
10.3.6 Australia Market Biopharmaceutical CDMO Service Forecast
10.4 Europe Biopharmaceutical CDMO Service Forecast by Country (2027-2032)
10.4.1 Germany Market Biopharmaceutical CDMO Service Forecast
10.4.2 France Market Biopharmaceutical CDMO Service Forecast
10.4.3 UK Market Biopharmaceutical CDMO Service Forecast
10.4.4 Italy Market Biopharmaceutical CDMO Service Forecast
10.4.5 Russia Market Biopharmaceutical CDMO Service Forecast
10.5 Middle East & Africa Biopharmaceutical CDMO Service Forecast by Region (2027-2032)
10.5.1 Egypt Market Biopharmaceutical CDMO Service Forecast
10.5.2 South Africa Market Biopharmaceutical CDMO Service Forecast
10.5.3 Israel Market Biopharmaceutical CDMO Service Forecast
10.5.4 Turkey Market Biopharmaceutical CDMO Service Forecast
10.6 Global Biopharmaceutical CDMO Service Forecast by Type (2027-2032)
10.7 Global Biopharmaceutical CDMO Service Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Biopharmaceutical CDMO Service Forecast
11 KEY PLAYERS ANALYSIS
11.1 Lonza
11.1.1 Lonza Company Information
11.1.2 Lonza Biopharmaceutical CDMO Service Product Offered
11.1.3 Lonza Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Lonza Main Business Overview
11.1.5 Lonza Latest Developments
11.2 Catalent
11.2.1 Catalent Company Information
11.2.2 Catalent Biopharmaceutical CDMO Service Product Offered
11.2.3 Catalent Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Catalent Main Business Overview
11.2.5 Catalent Latest Developments
11.3 Samsung Biologics
11.3.1 Samsung Biologics Company Information
11.3.2 Samsung Biologics Biopharmaceutical CDMO Service Product Offered
11.3.3 Samsung Biologics Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Samsung Biologics Main Business Overview
11.3.5 Samsung Biologics Latest Developments
11.4 FUJIFILM Diosynth Biotechnologies
11.4.1 FUJIFILM Diosynth Biotechnologies Company Information
11.4.2 FUJIFILM Diosynth Biotechnologies Biopharmaceutical CDMO Service Product Offered
11.4.3 FUJIFILM Diosynth Biotechnologies Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 FUJIFILM Diosynth Biotechnologies Main Business Overview
11.4.5 FUJIFILM Diosynth Biotechnologies Latest Developments
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Information
11.5.2 Boehringer Ingelheim Biopharmaceutical CDMO Service Product Offered
11.5.3 Boehringer Ingelheim Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Boehringer Ingelheim Main Business Overview
11.5.5 Boehringer Ingelheim Latest Developments
11.6 WuXi Biologics
11.6.1 WuXi Biologics Company Information
11.6.2 WuXi Biologics Biopharmaceutical CDMO Service Product Offered
11.6.3 WuXi Biologics Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 WuXi Biologics Main Business Overview
11.6.5 WuXi Biologics Latest Developments
11.7 Recipharm
11.7.1 Recipharm Company Information
11.7.2 Recipharm Biopharmaceutical CDMO Service Product Offered
11.7.3 Recipharm Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Recipharm Main Business Overview
11.7.5 Recipharm Latest Developments
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Information
11.8.2 Thermo Fisher Scientific Biopharmaceutical CDMO Service Product Offered
11.8.3 Thermo Fisher Scientific Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Thermo Fisher Scientific Main Business Overview
11.8.5 Thermo Fisher Scientific Latest Developments
11.9 AGC Biologics
11.9.1 AGC Biologics Company Information
11.9.2 AGC Biologics Biopharmaceutical CDMO Service Product Offered
11.9.3 AGC Biologics Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 AGC Biologics Main Business Overview
11.9.5 AGC Biologics Latest Developments
11.10 Rentschler Biopharma
11.10.1 Rentschler Biopharma Company Information
11.10.2 Rentschler Biopharma Biopharmaceutical CDMO Service Product Offered
11.10.3 Rentschler Biopharma Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Rentschler Biopharma Main Business Overview
11.10.5 Rentschler Biopharma Latest Developments
11.11 KBI Biopharma
11.11.1 KBI Biopharma Company Information
11.11.2 KBI Biopharma Biopharmaceutical CDMO Service Product Offered
11.11.3 KBI Biopharma Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 KBI Biopharma Main Business Overview
11.11.5 KBI Biopharma Latest Developments
11.12 Siegfried
11.12.1 Siegfried Company Information
11.12.2 Siegfried Biopharmaceutical CDMO Service Product Offered
11.12.3 Siegfried Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Siegfried Main Business Overview
11.12.5 Siegfried Latest Developments
11.13 Aenova Group
11.13.1 Aenova Group Company Information
11.13.2 Aenova Group Biopharmaceutical CDMO Service Product Offered
11.13.3 Aenova Group Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Aenova Group Main Business Overview
11.13.5 Aenova Group Latest Developments
11.14 GenScript
11.14.1 GenScript Company Information
11.14.2 GenScript Biopharmaceutical CDMO Service Product Offered
11.14.3 GenScript Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 GenScript Main Business Overview
11.14.5 GenScript Latest Developments
11.15 ProBioGen
11.15.1 ProBioGen Company Information
11.15.2 ProBioGen Biopharmaceutical CDMO Service Product Offered
11.15.3 ProBioGen Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 ProBioGen Main Business Overview
11.15.5 ProBioGen Latest Developments
11.16 Northway Biotech
11.16.1 Northway Biotech Company Information
11.16.2 Northway Biotech Biopharmaceutical CDMO Service Product Offered
11.16.3 Northway Biotech Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Northway Biotech Main Business Overview
11.16.5 Northway Biotech Latest Developments
11.17 3P Biopharmaceuticals
11.17.1 3P Biopharmaceuticals Company Information
11.17.2 3P Biopharmaceuticals Biopharmaceutical CDMO Service Product Offered
11.17.3 3P Biopharmaceuticals Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 3P Biopharmaceuticals Main Business Overview
11.17.5 3P Biopharmaceuticals Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biopharmaceutical CDMO Service Market Size (2021-2032)
2.1.2 Biopharmaceutical CDMO Service Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Biopharmaceutical CDMO Service by Country/Region (2021, 2025 & 2032)
2.2 Biopharmaceutical CDMO Service Segment by Type
2.2.1 Cell and Gene Therapies
2.2.2 Antibodies
2.2.3 Vaccines
2.2.4 Other
2.2.5 Biopharmaceutical CDMO Service Market Size by Type
2.2.5.1 Biopharmaceutical CDMO Service Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Biopharmaceutical CDMO Service Market Size Market Share by Type (2021-2026)
2.3 Biopharmaceutical CDMO Service Segment by Application
2.3.1 SMBs
2.3.2 Large Companies
2.3.3 Biopharmaceutical CDMO Service Market Size by Application
2.3.3.1 Biopharmaceutical CDMO Service Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.3.2 Global Biopharmaceutical CDMO Service Market Size Market Share by Application (2021-2026)
3 BIOPHARMACEUTICAL CDMO SERVICE MARKET SIZE BY PLAYER
3.1 Biopharmaceutical CDMO Service Market Size Market Share by Player
3.1.1 Global Biopharmaceutical CDMO Service Revenue by Player (2021-2026)
3.1.2 Global Biopharmaceutical CDMO Service Revenue Market Share by Player (2021-2026)
3.2 Global Biopharmaceutical CDMO Service Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 BIOPHARMACEUTICAL CDMO SERVICE BY REGION
4.1 Biopharmaceutical CDMO Service Market Size by Region (2021-2026)
4.2 Global Biopharmaceutical CDMO Service Annual Revenue by Country/Region (2021-2026)
4.3 Americas Biopharmaceutical CDMO Service Market Size Growth (2021-2026)
4.4 APAC Biopharmaceutical CDMO Service Market Size Growth (2021-2026)
4.5 Europe Biopharmaceutical CDMO Service Market Size Growth (2021-2026)
4.6 Middle East & Africa Biopharmaceutical CDMO Service Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Biopharmaceutical CDMO Service Market Size by Country (2021-2026)
5.2 Americas Biopharmaceutical CDMO Service Market Size by Type (2021-2026)
5.3 Americas Biopharmaceutical CDMO Service Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biopharmaceutical CDMO Service Market Size by Region (2021-2026)
6.2 APAC Biopharmaceutical CDMO Service Market Size by Type (2021-2026)
6.3 APAC Biopharmaceutical CDMO Service Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Biopharmaceutical CDMO Service Market Size by Country (2021-2026)
7.2 Europe Biopharmaceutical CDMO Service Market Size by Type (2021-2026)
7.3 Europe Biopharmaceutical CDMO Service Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biopharmaceutical CDMO Service by Region (2021-2026)
8.2 Middle East & Africa Biopharmaceutical CDMO Service Market Size by Type (2021-2026)
8.3 Middle East & Africa Biopharmaceutical CDMO Service Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL BIOPHARMACEUTICAL CDMO SERVICE MARKET FORECAST
10.1 Global Biopharmaceutical CDMO Service Forecast by Region (2027-2032)
10.1.1 Global Biopharmaceutical CDMO Service Forecast by Region (2027-2032)
10.1.2 Americas Biopharmaceutical CDMO Service Forecast
10.1.3 APAC Biopharmaceutical CDMO Service Forecast
10.1.4 Europe Biopharmaceutical CDMO Service Forecast
10.1.5 Middle East & Africa Biopharmaceutical CDMO Service Forecast
10.2 Americas Biopharmaceutical CDMO Service Forecast by Country (2027-2032)
10.2.1 United States Market Biopharmaceutical CDMO Service Forecast
10.2.2 Canada Market Biopharmaceutical CDMO Service Forecast
10.2.3 Mexico Market Biopharmaceutical CDMO Service Forecast
10.2.4 Brazil Market Biopharmaceutical CDMO Service Forecast
10.3 APAC Biopharmaceutical CDMO Service Forecast by Region (2027-2032)
10.3.1 China Biopharmaceutical CDMO Service Market Forecast
10.3.2 Japan Market Biopharmaceutical CDMO Service Forecast
10.3.3 Korea Market Biopharmaceutical CDMO Service Forecast
10.3.4 Southeast Asia Market Biopharmaceutical CDMO Service Forecast
10.3.5 India Market Biopharmaceutical CDMO Service Forecast
10.3.6 Australia Market Biopharmaceutical CDMO Service Forecast
10.4 Europe Biopharmaceutical CDMO Service Forecast by Country (2027-2032)
10.4.1 Germany Market Biopharmaceutical CDMO Service Forecast
10.4.2 France Market Biopharmaceutical CDMO Service Forecast
10.4.3 UK Market Biopharmaceutical CDMO Service Forecast
10.4.4 Italy Market Biopharmaceutical CDMO Service Forecast
10.4.5 Russia Market Biopharmaceutical CDMO Service Forecast
10.5 Middle East & Africa Biopharmaceutical CDMO Service Forecast by Region (2027-2032)
10.5.1 Egypt Market Biopharmaceutical CDMO Service Forecast
10.5.2 South Africa Market Biopharmaceutical CDMO Service Forecast
10.5.3 Israel Market Biopharmaceutical CDMO Service Forecast
10.5.4 Turkey Market Biopharmaceutical CDMO Service Forecast
10.6 Global Biopharmaceutical CDMO Service Forecast by Type (2027-2032)
10.7 Global Biopharmaceutical CDMO Service Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Biopharmaceutical CDMO Service Forecast
11 KEY PLAYERS ANALYSIS
11.1 Lonza
11.1.1 Lonza Company Information
11.1.2 Lonza Biopharmaceutical CDMO Service Product Offered
11.1.3 Lonza Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Lonza Main Business Overview
11.1.5 Lonza Latest Developments
11.2 Catalent
11.2.1 Catalent Company Information
11.2.2 Catalent Biopharmaceutical CDMO Service Product Offered
11.2.3 Catalent Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Catalent Main Business Overview
11.2.5 Catalent Latest Developments
11.3 Samsung Biologics
11.3.1 Samsung Biologics Company Information
11.3.2 Samsung Biologics Biopharmaceutical CDMO Service Product Offered
11.3.3 Samsung Biologics Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Samsung Biologics Main Business Overview
11.3.5 Samsung Biologics Latest Developments
11.4 FUJIFILM Diosynth Biotechnologies
11.4.1 FUJIFILM Diosynth Biotechnologies Company Information
11.4.2 FUJIFILM Diosynth Biotechnologies Biopharmaceutical CDMO Service Product Offered
11.4.3 FUJIFILM Diosynth Biotechnologies Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 FUJIFILM Diosynth Biotechnologies Main Business Overview
11.4.5 FUJIFILM Diosynth Biotechnologies Latest Developments
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Information
11.5.2 Boehringer Ingelheim Biopharmaceutical CDMO Service Product Offered
11.5.3 Boehringer Ingelheim Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Boehringer Ingelheim Main Business Overview
11.5.5 Boehringer Ingelheim Latest Developments
11.6 WuXi Biologics
11.6.1 WuXi Biologics Company Information
11.6.2 WuXi Biologics Biopharmaceutical CDMO Service Product Offered
11.6.3 WuXi Biologics Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 WuXi Biologics Main Business Overview
11.6.5 WuXi Biologics Latest Developments
11.7 Recipharm
11.7.1 Recipharm Company Information
11.7.2 Recipharm Biopharmaceutical CDMO Service Product Offered
11.7.3 Recipharm Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Recipharm Main Business Overview
11.7.5 Recipharm Latest Developments
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Information
11.8.2 Thermo Fisher Scientific Biopharmaceutical CDMO Service Product Offered
11.8.3 Thermo Fisher Scientific Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Thermo Fisher Scientific Main Business Overview
11.8.5 Thermo Fisher Scientific Latest Developments
11.9 AGC Biologics
11.9.1 AGC Biologics Company Information
11.9.2 AGC Biologics Biopharmaceutical CDMO Service Product Offered
11.9.3 AGC Biologics Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 AGC Biologics Main Business Overview
11.9.5 AGC Biologics Latest Developments
11.10 Rentschler Biopharma
11.10.1 Rentschler Biopharma Company Information
11.10.2 Rentschler Biopharma Biopharmaceutical CDMO Service Product Offered
11.10.3 Rentschler Biopharma Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Rentschler Biopharma Main Business Overview
11.10.5 Rentschler Biopharma Latest Developments
11.11 KBI Biopharma
11.11.1 KBI Biopharma Company Information
11.11.2 KBI Biopharma Biopharmaceutical CDMO Service Product Offered
11.11.3 KBI Biopharma Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 KBI Biopharma Main Business Overview
11.11.5 KBI Biopharma Latest Developments
11.12 Siegfried
11.12.1 Siegfried Company Information
11.12.2 Siegfried Biopharmaceutical CDMO Service Product Offered
11.12.3 Siegfried Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Siegfried Main Business Overview
11.12.5 Siegfried Latest Developments
11.13 Aenova Group
11.13.1 Aenova Group Company Information
11.13.2 Aenova Group Biopharmaceutical CDMO Service Product Offered
11.13.3 Aenova Group Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Aenova Group Main Business Overview
11.13.5 Aenova Group Latest Developments
11.14 GenScript
11.14.1 GenScript Company Information
11.14.2 GenScript Biopharmaceutical CDMO Service Product Offered
11.14.3 GenScript Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 GenScript Main Business Overview
11.14.5 GenScript Latest Developments
11.15 ProBioGen
11.15.1 ProBioGen Company Information
11.15.2 ProBioGen Biopharmaceutical CDMO Service Product Offered
11.15.3 ProBioGen Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 ProBioGen Main Business Overview
11.15.5 ProBioGen Latest Developments
11.16 Northway Biotech
11.16.1 Northway Biotech Company Information
11.16.2 Northway Biotech Biopharmaceutical CDMO Service Product Offered
11.16.3 Northway Biotech Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Northway Biotech Main Business Overview
11.16.5 Northway Biotech Latest Developments
11.17 3P Biopharmaceuticals
11.17.1 3P Biopharmaceuticals Company Information
11.17.2 3P Biopharmaceuticals Biopharmaceutical CDMO Service Product Offered
11.17.3 3P Biopharmaceuticals Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 3P Biopharmaceuticals Main Business Overview
11.17.5 3P Biopharmaceuticals Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Biopharmaceutical CDMO Service Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Biopharmaceutical CDMO Service Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Cell and Gene Therapies
Table 4. Major Players of Antibodies
Table 5. Major Players of Vaccines
Table 6. Major Players of Other
Table 7. Biopharmaceutical CDMO Service Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Biopharmaceutical CDMO Service Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Biopharmaceutical CDMO Service Market Size Market Share by Type (2021-2026)
Table 10. Biopharmaceutical CDMO Service Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Biopharmaceutical CDMO Service Market Size by Application (2021-2026) & ($ millions)
Table 12. Global Biopharmaceutical CDMO Service Market Size Market Share by Application (2021-2026)
Table 13. Global Biopharmaceutical CDMO Service Revenue by Player (2021-2026) & ($ millions)
Table 14. Global Biopharmaceutical CDMO Service Revenue Market Share by Player (2021-2026)
Table 15. Biopharmaceutical CDMO Service Key Players Head office and Products Offered
Table 16. Biopharmaceutical CDMO Service Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Biopharmaceutical CDMO Service Market Size by Region (2021-2026) & ($ millions)
Table 20. Global Biopharmaceutical CDMO Service Market Size Market Share by Region (2021-2026)
Table 21. Global Biopharmaceutical CDMO Service Revenue by Country/Region (2021-2026) & ($ millions)
Table 22. Global Biopharmaceutical CDMO Service Revenue Market Share by Country/Region (2021-2026)
Table 23. Americas Biopharmaceutical CDMO Service Market Size by Country (2021-2026) & ($ millions)
Table 24. Americas Biopharmaceutical CDMO Service Market Size Market Share by Country (2021-2026)
Table 25. Americas Biopharmaceutical CDMO Service Market Size by Type (2021-2026) & ($ millions)
Table 26. Americas Biopharmaceutical CDMO Service Market Size Market Share by Type (2021-2026)
Table 27. Americas Biopharmaceutical CDMO Service Market Size by Application (2021-2026) & ($ millions)
Table 28. Americas Biopharmaceutical CDMO Service Market Size Market Share by Application (2021-2026)
Table 29. APAC Biopharmaceutical CDMO Service Market Size by Region (2021-2026) & ($ millions)
Table 30. APAC Biopharmaceutical CDMO Service Market Size Market Share by Region (2021-2026)
Table 31. APAC Biopharmaceutical CDMO Service Market Size by Type (2021-2026) & ($ millions)
Table 32. APAC Biopharmaceutical CDMO Service Market Size by Application (2021-2026) & ($ millions)
Table 33. Europe Biopharmaceutical CDMO Service Market Size by Country (2021-2026) & ($ millions)
Table 34. Europe Biopharmaceutical CDMO Service Market Size Market Share by Country (2021-2026)
Table 35. Europe Biopharmaceutical CDMO Service Market Size by Type (2021-2026) & ($ millions)
Table 36. Europe Biopharmaceutical CDMO Service Market Size by Application (2021-2026) & ($ millions)
Table 37. Middle East & Africa Biopharmaceutical CDMO Service Market Size by Region (2021-2026) & ($ millions)
Table 38. Middle East & Africa Biopharmaceutical CDMO Service Market Size by Type (2021-2026) & ($ millions)
Table 39. Middle East & Africa Biopharmaceutical CDMO Service Market Size by Application (2021-2026) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Biopharmaceutical CDMO Service
Table 41. Key Market Challenges & Risks of Biopharmaceutical CDMO Service
Table 42. Key Industry Trends of Biopharmaceutical CDMO Service
Table 43. Global Biopharmaceutical CDMO Service Market Size Forecast by Region (2027-2032) & ($ millions)
Table 44. Global Biopharmaceutical CDMO Service Market Size Market Share Forecast by Region (2027-2032)
Table 45. Global Biopharmaceutical CDMO Service Market Size Forecast by Type (2027-2032) & ($ millions)
Table 46. Global Biopharmaceutical CDMO Service Market Size Forecast by Application (2027-2032) & ($ millions)
Table 47. Lonza Details, Company Type, Biopharmaceutical CDMO Service Area Served and Its Competitors
Table 48. Lonza Biopharmaceutical CDMO Service Product Offered
Table 49. Lonza Biopharmaceutical CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 50. Lonza Main Business
Table 51. Lonza Latest Developments
Table 52. Catalent Details, Company Type, Biopharmaceutical CDMO Service Area Served and Its Competitors
Table 53. Catalent Biopharmaceutical CDMO Service Product Offered
Table 54. Catalent Biopharmaceutical CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 55. Catalent Main Business
Table 56. Catalent Latest Developments
Table 57. Samsung Biologics Details, Company Type, Biopharmaceutical CDMO Service Area Served and Its Competitors
Table 58. Samsung Biologics Biopharmaceutical CDMO Service Product Offered
Table 59. Samsung Biologics Biopharmaceutical CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Samsung Biologics Main Business
Table 61. Samsung Biologics Latest Developments
Table 62. FUJIFILM Diosynth Biotechnologies Details, Company Type, Biopharmaceutical CDMO Service Area Served and Its Competitors
Table 63. FUJIFILM Diosynth Biotechnologies Biopharmaceutical CDMO Service Product Offered
Table 64. FUJIFILM Diosynth Biotechnologies Biopharmaceutical CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. FUJIFILM Diosynth Biotechnologies Main Business
Table 66. FUJIFILM Diosynth Biotechnologies Latest Developments
Table 67. Boehringer Ingelheim Details, Company Type, Biopharmaceutical CDMO Service Area Served and Its Competitors
Table 68. Boehringer Ingelheim Biopharmaceutical CDMO Service Product Offered
Table 69. Boehringer Ingelheim Biopharmaceutical CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. Boehringer Ingelheim Main Business
Table 71. Boehringer Ingelheim Latest Developments
Table 72. WuXi Biologics Details, Company Type, Biopharmaceutical CDMO Service Area Served and Its Competitors
Table 73. WuXi Biologics Biopharmaceutical CDMO Service Product Offered
Table 74. WuXi Biologics Biopharmaceutical CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. WuXi Biologics Main Business
Table 76. WuXi Biologics Latest Developments
Table 77. Recipharm Details, Company Type, Biopharmaceutical CDMO Service Area Served and Its Competitors
Table 78. Recipharm Biopharmaceutical CDMO Service Product Offered
Table 79. Recipharm Biopharmaceutical CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. Recipharm Main Business
Table 81. Recipharm Latest Developments
Table 82. Thermo Fisher Scientific Details, Company Type, Biopharmaceutical CDMO Service Area Served and Its Competitors
Table 83. Thermo Fisher Scientific Biopharmaceutical CDMO Service Product Offered
Table 84. Thermo Fisher Scientific Biopharmaceutical CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. Thermo Fisher Scientific Main Business
Table 86. Thermo Fisher Scientific Latest Developments
Table 87. AGC Biologics Details, Company Type, Biopharmaceutical CDMO Service Area Served and Its Competitors
Table 88. AGC Biologics Biopharmaceutical CDMO Service Product Offered
Table 89. AGC Biologics Biopharmaceutical CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. AGC Biologics Main Business
Table 91. AGC Biologics Latest Developments
Table 92. Rentschler Biopharma Details, Company Type, Biopharmaceutical CDMO Service Area Served and Its Competitors
Table 93. Rentschler Biopharma Biopharmaceutical CDMO Service Product Offered
Table 94. Rentschler Biopharma Biopharmaceutical CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. Rentschler Biopharma Main Business
Table 96. Rentschler Biopharma Latest Developments
Table 97. KBI Biopharma Details, Company Type, Biopharmaceutical CDMO Service Area Served and Its Competitors
Table 98. KBI Biopharma Biopharmaceutical CDMO Service Product Offered
Table 99. KBI Biopharma Biopharmaceutical CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. KBI Biopharma Main Business
Table 101. KBI Biopharma Latest Developments
Table 102. Siegfried Details, Company Type, Biopharmaceutical CDMO Service Area Served and Its Competitors
Table 103. Siegfried Biopharmaceutical CDMO Service Product Offered
Table 104. Siegfried Biopharmaceutical CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 105. Siegfried Main Business
Table 106. Siegfried Latest Developments
Table 107. Aenova Group Details, Company Type, Biopharmaceutical CDMO Service Area Served and Its Competitors
Table 108. Aenova Group Biopharmaceutical CDMO Service Product Offered
Table 109. Aenova Group Biopharmaceutical CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 110. Aenova Group Main Business
Table 111. Aenova Group Latest Developments
Table 112. GenScript Details, Company Type, Biopharmaceutical CDMO Service Area Served and Its Competitors
Table 113. GenScript Biopharmaceutical CDMO Service Product Offered
Table 114. GenScript Biopharmaceutical CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 115. GenScript Main Business
Table 116. GenScript Latest Developments
Table 117. ProBioGen Details, Company Type, Biopharmaceutical CDMO Service Area Served and Its Competitors
Table 118. ProBioGen Biopharmaceutical CDMO Service Product Offered
Table 119. ProBioGen Biopharmaceutical CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 120. ProBioGen Main Business
Table 121. ProBioGen Latest Developments
Table 122. Northway Biotech Details, Company Type, Biopharmaceutical CDMO Service Area Served and Its Competitors
Table 123. Northway Biotech Biopharmaceutical CDMO Service Product Offered
Table 124. Northway Biotech Biopharmaceutical CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 125. Northway Biotech Main Business
Table 126. Northway Biotech Latest Developments
Table 127. 3P Biopharmaceuticals Details, Company Type, Biopharmaceutical CDMO Service Area Served and Its Competitors
Table 128. 3P Biopharmaceuticals Biopharmaceutical CDMO Service Product Offered
Table 129. 3P Biopharmaceuticals Biopharmaceutical CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 130. 3P Biopharmaceuticals Main Business
Table 131. 3P Biopharmaceuticals Latest Developments
Table 1. Biopharmaceutical CDMO Service Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Biopharmaceutical CDMO Service Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Cell and Gene Therapies
Table 4. Major Players of Antibodies
Table 5. Major Players of Vaccines
Table 6. Major Players of Other
Table 7. Biopharmaceutical CDMO Service Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Biopharmaceutical CDMO Service Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Biopharmaceutical CDMO Service Market Size Market Share by Type (2021-2026)
Table 10. Biopharmaceutical CDMO Service Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Biopharmaceutical CDMO Service Market Size by Application (2021-2026) & ($ millions)
Table 12. Global Biopharmaceutical CDMO Service Market Size Market Share by Application (2021-2026)
Table 13. Global Biopharmaceutical CDMO Service Revenue by Player (2021-2026) & ($ millions)
Table 14. Global Biopharmaceutical CDMO Service Revenue Market Share by Player (2021-2026)
Table 15. Biopharmaceutical CDMO Service Key Players Head office and Products Offered
Table 16. Biopharmaceutical CDMO Service Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Biopharmaceutical CDMO Service Market Size by Region (2021-2026) & ($ millions)
Table 20. Global Biopharmaceutical CDMO Service Market Size Market Share by Region (2021-2026)
Table 21. Global Biopharmaceutical CDMO Service Revenue by Country/Region (2021-2026) & ($ millions)
Table 22. Global Biopharmaceutical CDMO Service Revenue Market Share by Country/Region (2021-2026)
Table 23. Americas Biopharmaceutical CDMO Service Market Size by Country (2021-2026) & ($ millions)
Table 24. Americas Biopharmaceutical CDMO Service Market Size Market Share by Country (2021-2026)
Table 25. Americas Biopharmaceutical CDMO Service Market Size by Type (2021-2026) & ($ millions)
Table 26. Americas Biopharmaceutical CDMO Service Market Size Market Share by Type (2021-2026)
Table 27. Americas Biopharmaceutical CDMO Service Market Size by Application (2021-2026) & ($ millions)
Table 28. Americas Biopharmaceutical CDMO Service Market Size Market Share by Application (2021-2026)
Table 29. APAC Biopharmaceutical CDMO Service Market Size by Region (2021-2026) & ($ millions)
Table 30. APAC Biopharmaceutical CDMO Service Market Size Market Share by Region (2021-2026)
Table 31. APAC Biopharmaceutical CDMO Service Market Size by Type (2021-2026) & ($ millions)
Table 32. APAC Biopharmaceutical CDMO Service Market Size by Application (2021-2026) & ($ millions)
Table 33. Europe Biopharmaceutical CDMO Service Market Size by Country (2021-2026) & ($ millions)
Table 34. Europe Biopharmaceutical CDMO Service Market Size Market Share by Country (2021-2026)
Table 35. Europe Biopharmaceutical CDMO Service Market Size by Type (2021-2026) & ($ millions)
Table 36. Europe Biopharmaceutical CDMO Service Market Size by Application (2021-2026) & ($ millions)
Table 37. Middle East & Africa Biopharmaceutical CDMO Service Market Size by Region (2021-2026) & ($ millions)
Table 38. Middle East & Africa Biopharmaceutical CDMO Service Market Size by Type (2021-2026) & ($ millions)
Table 39. Middle East & Africa Biopharmaceutical CDMO Service Market Size by Application (2021-2026) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Biopharmaceutical CDMO Service
Table 41. Key Market Challenges & Risks of Biopharmaceutical CDMO Service
Table 42. Key Industry Trends of Biopharmaceutical CDMO Service
Table 43. Global Biopharmaceutical CDMO Service Market Size Forecast by Region (2027-2032) & ($ millions)
Table 44. Global Biopharmaceutical CDMO Service Market Size Market Share Forecast by Region (2027-2032)
Table 45. Global Biopharmaceutical CDMO Service Market Size Forecast by Type (2027-2032) & ($ millions)
Table 46. Global Biopharmaceutical CDMO Service Market Size Forecast by Application (2027-2032) & ($ millions)
Table 47. Lonza Details, Company Type, Biopharmaceutical CDMO Service Area Served and Its Competitors
Table 48. Lonza Biopharmaceutical CDMO Service Product Offered
Table 49. Lonza Biopharmaceutical CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 50. Lonza Main Business
Table 51. Lonza Latest Developments
Table 52. Catalent Details, Company Type, Biopharmaceutical CDMO Service Area Served and Its Competitors
Table 53. Catalent Biopharmaceutical CDMO Service Product Offered
Table 54. Catalent Biopharmaceutical CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 55. Catalent Main Business
Table 56. Catalent Latest Developments
Table 57. Samsung Biologics Details, Company Type, Biopharmaceutical CDMO Service Area Served and Its Competitors
Table 58. Samsung Biologics Biopharmaceutical CDMO Service Product Offered
Table 59. Samsung Biologics Biopharmaceutical CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Samsung Biologics Main Business
Table 61. Samsung Biologics Latest Developments
Table 62. FUJIFILM Diosynth Biotechnologies Details, Company Type, Biopharmaceutical CDMO Service Area Served and Its Competitors
Table 63. FUJIFILM Diosynth Biotechnologies Biopharmaceutical CDMO Service Product Offered
Table 64. FUJIFILM Diosynth Biotechnologies Biopharmaceutical CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. FUJIFILM Diosynth Biotechnologies Main Business
Table 66. FUJIFILM Diosynth Biotechnologies Latest Developments
Table 67. Boehringer Ingelheim Details, Company Type, Biopharmaceutical CDMO Service Area Served and Its Competitors
Table 68. Boehringer Ingelheim Biopharmaceutical CDMO Service Product Offered
Table 69. Boehringer Ingelheim Biopharmaceutical CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. Boehringer Ingelheim Main Business
Table 71. Boehringer Ingelheim Latest Developments
Table 72. WuXi Biologics Details, Company Type, Biopharmaceutical CDMO Service Area Served and Its Competitors
Table 73. WuXi Biologics Biopharmaceutical CDMO Service Product Offered
Table 74. WuXi Biologics Biopharmaceutical CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. WuXi Biologics Main Business
Table 76. WuXi Biologics Latest Developments
Table 77. Recipharm Details, Company Type, Biopharmaceutical CDMO Service Area Served and Its Competitors
Table 78. Recipharm Biopharmaceutical CDMO Service Product Offered
Table 79. Recipharm Biopharmaceutical CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. Recipharm Main Business
Table 81. Recipharm Latest Developments
Table 82. Thermo Fisher Scientific Details, Company Type, Biopharmaceutical CDMO Service Area Served and Its Competitors
Table 83. Thermo Fisher Scientific Biopharmaceutical CDMO Service Product Offered
Table 84. Thermo Fisher Scientific Biopharmaceutical CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. Thermo Fisher Scientific Main Business
Table 86. Thermo Fisher Scientific Latest Developments
Table 87. AGC Biologics Details, Company Type, Biopharmaceutical CDMO Service Area Served and Its Competitors
Table 88. AGC Biologics Biopharmaceutical CDMO Service Product Offered
Table 89. AGC Biologics Biopharmaceutical CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. AGC Biologics Main Business
Table 91. AGC Biologics Latest Developments
Table 92. Rentschler Biopharma Details, Company Type, Biopharmaceutical CDMO Service Area Served and Its Competitors
Table 93. Rentschler Biopharma Biopharmaceutical CDMO Service Product Offered
Table 94. Rentschler Biopharma Biopharmaceutical CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. Rentschler Biopharma Main Business
Table 96. Rentschler Biopharma Latest Developments
Table 97. KBI Biopharma Details, Company Type, Biopharmaceutical CDMO Service Area Served and Its Competitors
Table 98. KBI Biopharma Biopharmaceutical CDMO Service Product Offered
Table 99. KBI Biopharma Biopharmaceutical CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. KBI Biopharma Main Business
Table 101. KBI Biopharma Latest Developments
Table 102. Siegfried Details, Company Type, Biopharmaceutical CDMO Service Area Served and Its Competitors
Table 103. Siegfried Biopharmaceutical CDMO Service Product Offered
Table 104. Siegfried Biopharmaceutical CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 105. Siegfried Main Business
Table 106. Siegfried Latest Developments
Table 107. Aenova Group Details, Company Type, Biopharmaceutical CDMO Service Area Served and Its Competitors
Table 108. Aenova Group Biopharmaceutical CDMO Service Product Offered
Table 109. Aenova Group Biopharmaceutical CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 110. Aenova Group Main Business
Table 111. Aenova Group Latest Developments
Table 112. GenScript Details, Company Type, Biopharmaceutical CDMO Service Area Served and Its Competitors
Table 113. GenScript Biopharmaceutical CDMO Service Product Offered
Table 114. GenScript Biopharmaceutical CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 115. GenScript Main Business
Table 116. GenScript Latest Developments
Table 117. ProBioGen Details, Company Type, Biopharmaceutical CDMO Service Area Served and Its Competitors
Table 118. ProBioGen Biopharmaceutical CDMO Service Product Offered
Table 119. ProBioGen Biopharmaceutical CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 120. ProBioGen Main Business
Table 121. ProBioGen Latest Developments
Table 122. Northway Biotech Details, Company Type, Biopharmaceutical CDMO Service Area Served and Its Competitors
Table 123. Northway Biotech Biopharmaceutical CDMO Service Product Offered
Table 124. Northway Biotech Biopharmaceutical CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 125. Northway Biotech Main Business
Table 126. Northway Biotech Latest Developments
Table 127. 3P Biopharmaceuticals Details, Company Type, Biopharmaceutical CDMO Service Area Served and Its Competitors
Table 128. 3P Biopharmaceuticals Biopharmaceutical CDMO Service Product Offered
Table 129. 3P Biopharmaceuticals Biopharmaceutical CDMO Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 130. 3P Biopharmaceuticals Main Business
Table 131. 3P Biopharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Biopharmaceutical CDMO Service Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Biopharmaceutical CDMO Service Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Biopharmaceutical CDMO Service Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Biopharmaceutical CDMO Service Sales Market Share by Country/Region (2025)
Figure 8. Biopharmaceutical CDMO Service Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Biopharmaceutical CDMO Service Market Size Market Share by Type in 2025
Figure 10. Biopharmaceutical CDMO Service in SMBs
Figure 11. Global Biopharmaceutical CDMO Service Market: SMBs (2021-2026) & ($ millions)
Figure 12. Biopharmaceutical CDMO Service in Large Companies
Figure 13. Global Biopharmaceutical CDMO Service Market: Large Companies (2021-2026) & ($ millions)
Figure 14. Global Biopharmaceutical CDMO Service Market Size Market Share by Application in 2025
Figure 15. Global Biopharmaceutical CDMO Service Revenue Market Share by Player in 2025
Figure 16. Global Biopharmaceutical CDMO Service Market Size Market Share by Region (2021-2026)
Figure 17. Americas Biopharmaceutical CDMO Service Market Size 2021-2026 ($ millions)
Figure 18. APAC Biopharmaceutical CDMO Service Market Size 2021-2026 ($ millions)
Figure 19. Europe Biopharmaceutical CDMO Service Market Size 2021-2026 ($ millions)
Figure 20. Middle East & Africa Biopharmaceutical CDMO Service Market Size 2021-2026 ($ millions)
Figure 21. Americas Biopharmaceutical CDMO Service Value Market Share by Country in 2025
Figure 22. United States Biopharmaceutical CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 23. Canada Biopharmaceutical CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 24. Mexico Biopharmaceutical CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 25. Brazil Biopharmaceutical CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 26. APAC Biopharmaceutical CDMO Service Market Size Market Share by Region in 2025
Figure 27. APAC Biopharmaceutical CDMO Service Market Size Market Share by Type (2021-2026)
Figure 28. APAC Biopharmaceutical CDMO Service Market Size Market Share by Application (2021-2026)
Figure 29. China Biopharmaceutical CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 30. Japan Biopharmaceutical CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 31. South Korea Biopharmaceutical CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 32. Southeast Asia Biopharmaceutical CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 33. India Biopharmaceutical CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 34. Australia Biopharmaceutical CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 35. Europe Biopharmaceutical CDMO Service Market Size Market Share by Country in 2025
Figure 36. Europe Biopharmaceutical CDMO Service Market Size Market Share by Type (2021-2026)
Figure 37. Europe Biopharmaceutical CDMO Service Market Size Market Share by Application (2021-2026)
Figure 38. Germany Biopharmaceutical CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 39. France Biopharmaceutical CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 40. UK Biopharmaceutical CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 41. Italy Biopharmaceutical CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 42. Russia Biopharmaceutical CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 43. Middle East & Africa Biopharmaceutical CDMO Service Market Size Market Share by Region (2021-2026)
Figure 44. Middle East & Africa Biopharmaceutical CDMO Service Market Size Market Share by Type (2021-2026)
Figure 45. Middle East & Africa Biopharmaceutical CDMO Service Market Size Market Share by Application (2021-2026)
Figure 46. Egypt Biopharmaceutical CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 47. South Africa Biopharmaceutical CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 48. Israel Biopharmaceutical CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 49. Turkey Biopharmaceutical CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 50. GCC Countries Biopharmaceutical CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 51. Americas Biopharmaceutical CDMO Service Market Size 2027-2032 ($ millions)
Figure 52. APAC Biopharmaceutical CDMO Service Market Size 2027-2032 ($ millions)
Figure 53. Europe Biopharmaceutical CDMO Service Market Size 2027-2032 ($ millions)
Figure 54. Middle East & Africa Biopharmaceutical CDMO Service Market Size 2027-2032 ($ millions)
Figure 55. United States Biopharmaceutical CDMO Service Market Size 2027-2032 ($ millions)
Figure 56. Canada Biopharmaceutical CDMO Service Market Size 2027-2032 ($ millions)
Figure 57. Mexico Biopharmaceutical CDMO Service Market Size 2027-2032 ($ millions)
Figure 58. Brazil Biopharmaceutical CDMO Service Market Size 2027-2032 ($ millions)
Figure 59. China Biopharmaceutical CDMO Service Market Size 2027-2032 ($ millions)
Figure 60. Japan Biopharmaceutical CDMO Service Market Size 2027-2032 ($ millions)
Figure 61. Korea Biopharmaceutical CDMO Service Market Size 2027-2032 ($ millions)
Figure 62. Southeast Asia Biopharmaceutical CDMO Service Market Size 2027-2032 ($ millions)
Figure 63. India Biopharmaceutical CDMO Service Market Size 2027-2032 ($ millions)
Figure 64. Australia Biopharmaceutical CDMO Service Market Size 2027-2032 ($ millions)
Figure 65. Germany Biopharmaceutical CDMO Service Market Size 2027-2032 ($ millions)
Figure 66. France Biopharmaceutical CDMO Service Market Size 2027-2032 ($ millions)
Figure 67. UK Biopharmaceutical CDMO Service Market Size 2027-2032 ($ millions)
Figure 68. Italy Biopharmaceutical CDMO Service Market Size 2027-2032 ($ millions)
Figure 69. Russia Biopharmaceutical CDMO Service Market Size 2027-2032 ($ millions)
Figure 70. Egypt Biopharmaceutical CDMO Service Market Size 2027-2032 ($ millions)
Figure 71. South Africa Biopharmaceutical CDMO Service Market Size 2027-2032 ($ millions)
Figure 72. Israel Biopharmaceutical CDMO Service Market Size 2027-2032 ($ millions)
Figure 73. Turkey Biopharmaceutical CDMO Service Market Size 2027-2032 ($ millions)
Figure 74. Global Biopharmaceutical CDMO Service Market Size Market Share Forecast by Type (2027-2032)
Figure 75. Global Biopharmaceutical CDMO Service Market Size Market Share Forecast by Application (2027-2032)
Figure 76. GCC Countries Biopharmaceutical CDMO Service Market Size 2027-2032 ($ millions)
Figure 1. Biopharmaceutical CDMO Service Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Biopharmaceutical CDMO Service Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Biopharmaceutical CDMO Service Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Biopharmaceutical CDMO Service Sales Market Share by Country/Region (2025)
Figure 8. Biopharmaceutical CDMO Service Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Biopharmaceutical CDMO Service Market Size Market Share by Type in 2025
Figure 10. Biopharmaceutical CDMO Service in SMBs
Figure 11. Global Biopharmaceutical CDMO Service Market: SMBs (2021-2026) & ($ millions)
Figure 12. Biopharmaceutical CDMO Service in Large Companies
Figure 13. Global Biopharmaceutical CDMO Service Market: Large Companies (2021-2026) & ($ millions)
Figure 14. Global Biopharmaceutical CDMO Service Market Size Market Share by Application in 2025
Figure 15. Global Biopharmaceutical CDMO Service Revenue Market Share by Player in 2025
Figure 16. Global Biopharmaceutical CDMO Service Market Size Market Share by Region (2021-2026)
Figure 17. Americas Biopharmaceutical CDMO Service Market Size 2021-2026 ($ millions)
Figure 18. APAC Biopharmaceutical CDMO Service Market Size 2021-2026 ($ millions)
Figure 19. Europe Biopharmaceutical CDMO Service Market Size 2021-2026 ($ millions)
Figure 20. Middle East & Africa Biopharmaceutical CDMO Service Market Size 2021-2026 ($ millions)
Figure 21. Americas Biopharmaceutical CDMO Service Value Market Share by Country in 2025
Figure 22. United States Biopharmaceutical CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 23. Canada Biopharmaceutical CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 24. Mexico Biopharmaceutical CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 25. Brazil Biopharmaceutical CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 26. APAC Biopharmaceutical CDMO Service Market Size Market Share by Region in 2025
Figure 27. APAC Biopharmaceutical CDMO Service Market Size Market Share by Type (2021-2026)
Figure 28. APAC Biopharmaceutical CDMO Service Market Size Market Share by Application (2021-2026)
Figure 29. China Biopharmaceutical CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 30. Japan Biopharmaceutical CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 31. South Korea Biopharmaceutical CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 32. Southeast Asia Biopharmaceutical CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 33. India Biopharmaceutical CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 34. Australia Biopharmaceutical CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 35. Europe Biopharmaceutical CDMO Service Market Size Market Share by Country in 2025
Figure 36. Europe Biopharmaceutical CDMO Service Market Size Market Share by Type (2021-2026)
Figure 37. Europe Biopharmaceutical CDMO Service Market Size Market Share by Application (2021-2026)
Figure 38. Germany Biopharmaceutical CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 39. France Biopharmaceutical CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 40. UK Biopharmaceutical CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 41. Italy Biopharmaceutical CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 42. Russia Biopharmaceutical CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 43. Middle East & Africa Biopharmaceutical CDMO Service Market Size Market Share by Region (2021-2026)
Figure 44. Middle East & Africa Biopharmaceutical CDMO Service Market Size Market Share by Type (2021-2026)
Figure 45. Middle East & Africa Biopharmaceutical CDMO Service Market Size Market Share by Application (2021-2026)
Figure 46. Egypt Biopharmaceutical CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 47. South Africa Biopharmaceutical CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 48. Israel Biopharmaceutical CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 49. Turkey Biopharmaceutical CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 50. GCC Countries Biopharmaceutical CDMO Service Market Size Growth 2021-2026 ($ millions)
Figure 51. Americas Biopharmaceutical CDMO Service Market Size 2027-2032 ($ millions)
Figure 52. APAC Biopharmaceutical CDMO Service Market Size 2027-2032 ($ millions)
Figure 53. Europe Biopharmaceutical CDMO Service Market Size 2027-2032 ($ millions)
Figure 54. Middle East & Africa Biopharmaceutical CDMO Service Market Size 2027-2032 ($ millions)
Figure 55. United States Biopharmaceutical CDMO Service Market Size 2027-2032 ($ millions)
Figure 56. Canada Biopharmaceutical CDMO Service Market Size 2027-2032 ($ millions)
Figure 57. Mexico Biopharmaceutical CDMO Service Market Size 2027-2032 ($ millions)
Figure 58. Brazil Biopharmaceutical CDMO Service Market Size 2027-2032 ($ millions)
Figure 59. China Biopharmaceutical CDMO Service Market Size 2027-2032 ($ millions)
Figure 60. Japan Biopharmaceutical CDMO Service Market Size 2027-2032 ($ millions)
Figure 61. Korea Biopharmaceutical CDMO Service Market Size 2027-2032 ($ millions)
Figure 62. Southeast Asia Biopharmaceutical CDMO Service Market Size 2027-2032 ($ millions)
Figure 63. India Biopharmaceutical CDMO Service Market Size 2027-2032 ($ millions)
Figure 64. Australia Biopharmaceutical CDMO Service Market Size 2027-2032 ($ millions)
Figure 65. Germany Biopharmaceutical CDMO Service Market Size 2027-2032 ($ millions)
Figure 66. France Biopharmaceutical CDMO Service Market Size 2027-2032 ($ millions)
Figure 67. UK Biopharmaceutical CDMO Service Market Size 2027-2032 ($ millions)
Figure 68. Italy Biopharmaceutical CDMO Service Market Size 2027-2032 ($ millions)
Figure 69. Russia Biopharmaceutical CDMO Service Market Size 2027-2032 ($ millions)
Figure 70. Egypt Biopharmaceutical CDMO Service Market Size 2027-2032 ($ millions)
Figure 71. South Africa Biopharmaceutical CDMO Service Market Size 2027-2032 ($ millions)
Figure 72. Israel Biopharmaceutical CDMO Service Market Size 2027-2032 ($ millions)
Figure 73. Turkey Biopharmaceutical CDMO Service Market Size 2027-2032 ($ millions)
Figure 74. Global Biopharmaceutical CDMO Service Market Size Market Share Forecast by Type (2027-2032)
Figure 75. Global Biopharmaceutical CDMO Service Market Size Market Share Forecast by Application (2027-2032)
Figure 76. GCC Countries Biopharmaceutical CDMO Service Market Size 2027-2032 ($ millions)
